therapeutic 1,141 words KG: ent-gene-679b721f
Contents

GPR37 Modulator Therapy for Parkinson's Disease

🔬 Protein Info
Gene Symbolent-gene-679b721f
Mendelian mutationsGPR37 loss-of-function mutations cause autosomal recessive juvenile parkinsonism with features resembling PARK2 (PARKIN) mutations
Association with sporadic PDGPR37 polymorphisms are associated with altered PD risk in genome-wide association studies[@liu2021]
Co-localization with PARKINGPR37 physically interacts with PARKIN, the E3 ubiquitin ligase mutated in the second most common form of familial PD
Orphan receptorDespite structural similarity to endothelin receptors, no definitive endogenous ligand has been established
Constitutively activeExhibits baseline signaling activity independent of ligand
G protein couplingPrimarily Gi/Go-coupled, inhibiting adenylate cyclase
β-arrestin pathwaySignals through β-arrestin-dependent mechanisms independent of G proteins
ER retentionMutant GPR37 is retained in the ER, causing cellular stress
KG Connections2 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (35)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.38
Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution
Score: 0.68
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.82
Vagal Afferent Microbial Signal Modulation
Score: 0.62
Vocal Cord Neuroplasticity Stimulation
Score: 0.52
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.90
Circadian Clock-Autophagy Synchronization
Score: 0.76
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.75
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.74
PARP1 Inhibition Therapy
Score: 0.74
CYP46A1 Overexpression Gene Therapy
Score: 0.73
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.71
Orexin-Microglia Modulation Therapy
Score: 0.71
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.71
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.70
Lysosomal Calcium Channel Modulation Therapy
Score: 0.70
Complement C1q Mimetic Decoy Therapy
Score: 0.69
Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.69
Ganglioside Rebalancing Therapy
Score: 0.69
pg 1/2Next →

Related Analyses (30)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
Synaptic pruning by microglia in early AD
neurodegeneration · completed
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · completed
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived

Related Experiments (30)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.45
AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera
validation · proposed · Score: 0.40
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40
AAV Serotype Comparison for LRRK2 Knockdown in PD
validation · proposed · Score: 0.40

Knowledge Graph (2 edges)

ent-gene-679b721f data_in benchmark_ot_ad_answer_key:GPR37
benchmark_ot_ad_answer_key:GPR37 data_in ent-gene-679b721f

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.